showed that CD30L deficiency promote the accumulation of MDSCs, increase the expression of PD-L1 on MDSCs and TAMs, and enhance immunosuppressive function in an AOM/DSS-induced CAC model, suggesting that CD30L/CD30 signaling could be a potential candidate target for immunotherapy in CAC (148). This evidence concerns the gene TNFSF8 and infectious otitis media.